ATE511647T1 - Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper - Google Patents

Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper

Info

Publication number
ATE511647T1
ATE511647T1 AT06731744T AT06731744T ATE511647T1 AT E511647 T1 ATE511647 T1 AT E511647T1 AT 06731744 T AT06731744 T AT 06731744T AT 06731744 T AT06731744 T AT 06731744T AT E511647 T1 ATE511647 T1 AT E511647T1
Authority
AT
Austria
Prior art keywords
amino acid
determination
acid sequence
releasing peptide
acid residue
Prior art date
Application number
AT06731744T
Other languages
English (en)
Inventor
Katsumi Aoyagi
Original Assignee
Advanced Life Science Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37307796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE511647(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Life Science Inst Inc filed Critical Advanced Life Science Inst Inc
Application granted granted Critical
Publication of ATE511647T1 publication Critical patent/ATE511647T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57423Specifically defined cancers of lung
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57572Gastrin releasing peptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/02Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/5758Gastrin releasing peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT06731744T 2005-04-13 2006-04-13 Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper ATE511647T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005115782 2005-04-13
JP2006007808 2006-04-13

Publications (1)

Publication Number Publication Date
ATE511647T1 true ATE511647T1 (de) 2011-06-15

Family

ID=37307796

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06731744T ATE511647T1 (de) 2005-04-13 2006-04-13 Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper

Country Status (9)

Country Link
US (1) US7927814B2 (de)
EP (1) EP1876445B1 (de)
JP (1) JP4950880B2 (de)
KR (1) KR101282811B1 (de)
CN (1) CN101160526B (de)
AT (1) ATE511647T1 (de)
CA (1) CA2604608C (de)
ES (1) ES2364185T3 (de)
WO (1) WO2006117994A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5201822B2 (ja) 2006-12-11 2013-06-05 アボット・ラボラトリーズ ガストリン放出ペプチド前駆体の免疫学的測定方法
EP2214016B1 (de) * 2007-10-26 2014-09-10 Advanced Life Science Institute, Inc. Gegen progastrin freisetzendes peptid gerichteter antikörper und verwendung davon
CN104089949A (zh) * 2014-06-27 2014-10-08 江苏福隆生物技术有限公司 胃泌素释放肽前体定量测定试剂盒、其制备方法及检测方法
CN105067599A (zh) * 2015-08-05 2015-11-18 南京闻智生物科技有限公司 一种检测胃泌素释放肽前体的化学发光免疫检测试剂盒
CN110945025B (zh) * 2017-03-30 2023-11-03 Ecs前胃泌素股份有限公司 用于检测前列腺癌的组合物和方法
CN109239348B (zh) * 2017-07-11 2022-03-08 北京科卫临床诊断试剂有限公司 胃泌素释放肽前体检测试剂盒用抗体及试剂盒
EP3672626A1 (de) * 2017-08-22 2020-07-01 Onkologix Ltd Zusammensetzung aus tumorassoziierten proliferativen peptiden und zugehöriges antikrebsimmunogen zur behandlung von lungenkrebs und anderen krebsen
CN108982858B (zh) * 2018-07-05 2021-06-15 陕西师范大学 一种基于单克隆抗体检测人proGRP的双夹心ELISA试剂盒
CN111349160B (zh) * 2018-12-24 2021-12-03 东莞市朋志生物科技有限公司 一种抗人胃泌素释放肽前体的重组抗体
CN109870570A (zh) * 2018-12-29 2019-06-11 广东云天抗体生物科技有限公司 一种检测猴il-18的酶联免疫试剂盒
CN109870571A (zh) * 2018-12-29 2019-06-11 广东云天抗体生物科技有限公司 一种检测猴g-csf的酶联免疫试剂盒
CN113583124B (zh) * 2021-06-16 2023-12-15 中国辐射防护研究院 一种抗前胃泌素释放肽单克隆抗体及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3148695A1 (de) * 1981-12-09 1983-07-21 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 4,4'-dibenzoylaminodianthrimidcarbazol
JP3210994B2 (ja) 1992-06-12 2001-09-25 株式会社先端生命科学研究所 ヒトガストリン放出ペプチド前駆体に対する抗体及びその使用
EP0811683B1 (de) * 1996-06-03 2008-01-23 Ken Yamaguchi Antikörper gegen den menschlichen gastrinfreisetzenden Peptidvorläufer und deren Verwendung
US6504010B1 (en) * 1999-06-30 2003-01-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AU2003234623A1 (en) * 2002-05-16 2003-12-02 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening

Also Published As

Publication number Publication date
KR20080003325A (ko) 2008-01-07
ES2364185T3 (es) 2011-08-26
JP4950880B2 (ja) 2012-06-13
EP1876445A4 (de) 2009-03-18
CA2604608A1 (en) 2006-11-09
US7927814B2 (en) 2011-04-19
EP1876445A1 (de) 2008-01-09
KR101282811B1 (ko) 2013-07-05
WO2006117994A1 (ja) 2006-11-09
CA2604608C (en) 2013-11-19
CN101160526B (zh) 2013-03-06
CN101160526A (zh) 2008-04-09
US20080182281A1 (en) 2008-07-31
JPWO2006117994A1 (ja) 2008-12-18
EP1876445B1 (de) 2011-06-01

Similar Documents

Publication Publication Date Title
ATE511647T1 (de) Gegen gastrin-releasing-peptide-vorläufer gerichteter antikörper
WO2011022093A3 (en) Methods and devices for detecting the presence of an analyte in a sample
WO2011014879A3 (en) Assay tools and methods of use
Wahl et al. Amino acid analysis for pharmacopoeial purposes
DK1639130T3 (da) Prober, biblioteker og kits til analyse af blandinger af nukleinsyrer og metoder til opbygning af disse
WO2005031005A3 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
WO2008089072A3 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
DE60028361D1 (de) Verfahren und zusammensetzungen zur karzinomdiagnose
MX2009009448A (es) Sensibilidad mejorada de determinacion de perfil de anticuerpos a traves de una colocacion en capas incrementada de anticuerpo reportero.
WO2009023331A3 (en) Antibodies and improved test sample handling methods for use in assays for myeloperoxidase
ATE455302T1 (de) Komplexformierungs- und -trennungsverfahren
WO2010000493A3 (en) Inorganic-binding peptides and quality control methods using them
GB0016814D0 (en) Improved dipstick assays (3)
WO2009131365A3 (ko) 위암 진단 마커로서의 cst1, dcc1, ifitm1 또는 melk
WO2009054091A1 (ja) ガストリン放出ペプチド前駆体に対する抗体及びその使用
EP1806363A4 (de) Verfahren zum nachweis vonhepatitis-b-virus-s-antigen
WO2011093606A3 (ko) Pna 기반의 실시간 pcr 클램핑을 이용한 braf 돌연변이 검출 방법 및 키트
ATE386111T1 (de) Zusammensetzungen, verfahren und kits zum nachweis eines antigens auf einer zelle und in einem biologischen gemisch
NZ596287A (en) Multiplex analysis of stacked transgenic protein
CN107543918A (zh) 一步法检测甲萘威残留的elisa试剂盒及其应用
WO2006133385A3 (en) Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
WO2020132408A3 (en) Compositions and methods for detecting plasmodium species nucleic acid
WO2006002841A3 (en) Analysis method
WO2008062479A3 (en) A high sensitivity assay for molecular typing of biological sample, probes and a kit thereof
ATE432469T1 (de) Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties